Stay updated on Belapectin for Esophageal Varices in NASH Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Belapectin for Esophageal Varices in NASH Cirrhosis Clinical Trial page.

Latest updates to the Belapectin for Esophageal Varices in NASH Cirrhosis Clinical Trial page
- ChecktodayChange DetectedThe web page has added a facility name and location details, while removing specific location terms and references to states, countries, and cities. This indicates a shift towards a more streamlined presentation of location information.SummaryDifference60%
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check29 days agoChange DetectedThe page has been updated to include new information about a clinical study evaluating the efficacy and safety of Belapectin for the prevention of esophageal varices in NASH cirrhosis, sponsored by Galectin Therapeutics Inc.SummaryDifference76%
- Check36 days agoChange DetectedThe page has undergone significant deletions, including a service alert about planned maintenance and important disclaimers regarding the safety and approval of studies listed on the site.SummaryDifference45%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.3%
Stay in the know with updates to Belapectin for Esophageal Varices in NASH Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belapectin for Esophageal Varices in NASH Cirrhosis Clinical Trial page.